Patent · US Active

Methods of enhancing adjuvaticity of vaccine compositions

US8916164B2 · kind B2 · utility

0Cited by
21References
21Claims
0Family size

Assignee

Inventor

Key dates

Filing dateAug 28, 2008
Grant dateDec 23, 2014
Priority date—
Expiry dateApr 21, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/55511
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The immunogenicity of vaccines is enhanced by co-administering a synthetic glycolipid, designated PBS-57, with the vaccine. PBS-57 has the ability to stimulate both a cell-mediated and humoral immune response. Co-administration of PBS-57 with a vaccine may be used in methods to stimulate one or more of a humoral immune response, a CD4+ T cell response, and a CD8+ cytotoxic T cell response.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.